Independent Factors for Prediction of Poor Outcomes in Patients with Febrile Neutropenia

被引:0
|
作者
Gunalp, Muge [1 ]
Koyunoglu, Merve [1 ]
Gurler, Serdar [1 ]
Koca, Ayca [1 ]
Yesilkaya, Ilker [1 ]
Oner, Emre [1 ]
Akkas, Meltem [2 ]
Aksu, Nalan Metin [2 ]
Demirkan, Arda [1 ]
Polat, Onur [1 ]
Elhan, Atilla Halil [3 ]
机构
[1] Ankara Univ, Sch Med, Dept Emergency Med, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Sch Med, Dept Emergency Med, Ankara, Turkey
[3] Ankara Univ, Sch Med, Dept Biostat, TR-06100 Ankara, Turkey
来源
MEDICAL SCIENCE MONITOR | 2014年 / 20卷
关键词
Antineoplastic Agents; Chemotherapy-Induced Febrile Neutropenia; Emergencies; CLINICAL-PRACTICE GUIDELINE; CANCER-RISK INDEX; MULTINATIONAL-ASSOCIATION; EMERGENCY-DEPARTMENT; SUPPORTIVE-CARE; HEMATOLOGIC MALIGNANCIES; FEVER; MANAGEMENT; DISCHARGE; DISEASE;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Febrile neutropenia (FN) is a life-threatening condition that requires urgent management in the emergency department (ED). Recent progress in the treatment of neutropenic fever has underscored the importance of risk stratification. In this study, we aimed to determine independent factors for prediction of poor outcomes in patients with FN. Material/Methods: We retrospectively evaluated 200 chemotherapy-induced febrile neutropenic patients who visited the ED. Upon arrival at the ED, clinical data, including sex, age, vital signs, underlying systemic diseases, laboratory test results, estimated GFR, blood cultures, CRP, radiologic examinations, and Multinational Association of Supportive Care in Cancer (MASCC) score of all febrile neutropenic patients were obtained. Outcomes were categorized as "poor" if serious complications during hospitalization, including death, occurred. Results: The platelet count <50 000 cells/mm(3) (OR 3.90, 95% CI 1.62-9.43), pulmonary infiltration (OR 3.45, 95% CI 1.48-8.07), hypoproteinemia <6 g/dl (OR 3.30, 95% CI 1.27-8.56), respiratory rate >24/min (OR 8.75, 95% CI 2.18-35.13), and MASCC score <21 (OR 9.20, 95% CI 3.98-21.26) were determined as independent risk factors for the prediction of death. The platelet count <50 000 cells/mm(3) (OR 3.93, 95% CI 1.42-10.92), serum CRP >50 mg/dl (OR 3.80, 95% CI 1.68-8.61), hypoproteinemia (OR 7.81, 95% CI 3.43-17.78), eGFR <= 90 ML/min/1.73 m(2) (OR 3.06, 95% CI 1.13-8.26), and MASCC score <21 (OR 3.45, 95% CI 1.53-7.79) were determined as independent risk factors for the prediction of poor clinical outcomes of FN patients. Platelet count, protein level, respiratory rate, pulmonary infiltration, CRP, MASCC score, and eGFR were shown to have a significant association with outcome. Conclusions: The results of our study may help emergency medicine physicians to prevent serious complications with proper use of simple independent risk factors besides MASCC score.
引用
收藏
页码:1826 / 1832
页数:7
相关论文
共 50 条
  • [1] Predictive factors for poor prognosis febrile neutropenia
    Ahn, Shin
    Lee, Yoon-Seon
    [J]. CURRENT OPINION IN ONCOLOGY, 2012, 24 (04) : 376 - 380
  • [2] Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia
    Shin Ahn
    Yoon-Seon Lee
    Yun-Hee Chun
    In-Ho Kwon
    Won Kim
    Kyung Soo Lim
    Tae Won Kim
    Kyoo-Hyung Lee
    [J]. Supportive Care in Cancer, 2011, 19 : 1151 - 1158
  • [3] Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia
    Ahn, Shin
    Lee, Yoon-Seon
    Chun, Yun-Hee
    Kwon, In-Ho
    Kim, Won
    Lim, Kyung Soo
    Kim, Tae Won
    Lee, Kyoo-Hyung
    [J]. SUPPORTIVE CARE IN CANCER, 2011, 19 (08) : 1151 - 1158
  • [4] Health and economic outcomes of patients with febrile neutropenia
    Manguso, AH
    Motl, SE
    Kuth, JC
    Suda, KJ
    [J]. PHARMACOTHERAPY, 2004, 24 (10): : 1452 - 1452
  • [5] PROGNOSTIC FACTORS FOR FEBRILE NEUTROPENIA IN HOSPITALIZED PATIENTS
    Hosiriluck, N.
    Klomjit, S.
    Sutamtewagul, G.
    Radhi, S.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (02) : 435 - 435
  • [6] Time to antibiotics and outcomes in cancer patients with febrile neutropenia
    Perron, Thomas
    Emara, Mohamed
    Ahmed, Shahid
    [J]. BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [7] Time to antibiotics and outcomes in cancer patients with febrile neutropenia
    Thomas Perron
    Mohamed Emara
    Shahid Ahmed
    [J]. BMC Health Services Research, 14
  • [8] OUTCOMES OF FEBRILE NEUTROPENIA IN CIRRHOTIC VERSUS NONCIRRHOTIC PATIENTS
    Dimachkie, Reem
    Alameddine, Zakaria
    Mustafa, Ahmad
    Alsheikh, Mira
    Wei, Chapman
    Afif, John
    El-Sayegh, Suzanne
    Deeb, Liliane
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S92 - S93
  • [9] Prognostic Factors Predicting Poor Outcome in Cancer Patients with Febrile Neutropenia in the Emergency Department: Usefulness of qSOFA
    Lee, Seung Jae
    Kim, Ji Hye
    Han, Seung Baik
    Paik, Jin Hui
    Durey, Aremn
    [J]. JOURNAL OF ONCOLOGY, 2018, 2018
  • [10] Risk Factors Predicting Outcome in Febrile Neutropenia Patients
    Aamir, S.
    Anwar, S.
    Faizan, M.
    Ahmad, A.
    [J]. PEDIATRIC BLOOD & CANCER, 2016, 63 : S98 - S98